Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Environmental Topics
  • Laws & Regulations
  • Report a Violation
  • About EPA
Risk Assessment
Contact Us

Proceedings of the Workshop on the Acceptability and Interpretation of Dermal Developmental Toxicity Studies

On this page:

  • Overview
  • History
  • Downloads

Alert
Alert Notice - This site contains archived material(s)

Archive disclaimer
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance. Please use the contact us form if you need additional support.

Abstract

The purpose of the workshop, which was held in April 1988, was to review the current state of knowledge on the use of the dermal route of exposure in developmental toxicity studies. n evaluating this area, three major issues were considered: 1) the evaluation of maternal toxicity in dermal developmental toxicity studies; 2) what types of pharmacokinetic data are necessary or desirable for the appropriate design and interpretation of these studies; and 3) what factors are important to consider in the design of dermal developmental toxicity studies. he participants concluded: 1) dermal developmental toxicity studies without any indication of maternal or develop mental toxicity are inadequate for risk assessment unless accompanied by absorption data, 2) absorption data and limited pharmacokinetic data should be collected in every dermal developmental toxicity study, and 3) dermal developmental toxicity studies in which skin irritation is too marked should be considered inadequate for risk assessment. eneral recommendations made for all developmental toxicity studies regardless of the route of exposure were: signs of local irritation should be examined, and absorption/pharmacokinetic data should be developed. reas in which additional research is needed were also identified.

Citation

Kimmel, C. AND E. Francis. Proceedings of the Workshop on the Acceptability and Interpretation of Dermal Developmental Toxicity Studies. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/J-90/001 (NTIS PB90242371), 1990.

History/Chronology

Additional Information

Fundamental & Applied Toxicology, 14:386-398, 1990

Download(s)

  • PROCEEDINGS OF THE WORKSHOP ON THE ACCEPTABILITY AND INTERPRETATION OF DERMAL DEVELOPMENTAL TOXICITY STUDIES
  • Risk Assessment Home
  • About Risk Assessment
  • Risk Recent Additions
  • Human Health Risk Assessment
  • Ecological Risk Assessment
  • Risk Advanced Search
    • Risk Publications
  • Risk Assessment Guidance
  • Risk Tools and Databases
  • Superfund Risk Assessment
  • Where you live
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on October 17, 2019
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshots
  • Grants
  • No FEAR Act Data
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Open Government
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions

Follow.